# Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma

> **NCT02659618** · — · COMPLETED · sponsor: **Rush University Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Severe Persistent Asthma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02659618
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2018-09-26
- **Final completion:** 2020-12-16
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-02-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02659618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02659618, "Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02659618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*